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Abstract: Allophylus cominia (L) Sw (Sapindaceae), is one of the most popular medicinal plant in Cuba. It is traditionally used in the 
treatment of diabetes. The aim of this study was to investigate the effect of A cominia leaves aqueous extract in a type 2 diabetes model 
induced by streptozotocin treatment in neonatal rats. Two experiments was executed: at 6 weeks old rats, before starting the plant 
evaluation, and at 11 weeks old rats, after the oral administration daily of three doses 0.25, 0.5 and 1.0 g/kg of A cominia aqueous extract 
during 3 weeks and plasma blood glucose level was evaluated. At 6 weeks old rats, the group of diabetic animals showed significant 
f diabetic 
animals treated w
0.05). Only the groups treated with 0.5 and 1.0 g/kg of A cominia extract showed a recovery of normal glycaemic values. Hence, it can be 
concluded that aqueous extract from A cominia leaves has antidiabetic properties and may be effective in the type 2 diabetes treatment.  
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Resumen: Allophylus cominia (L) Sw (Sapindaceae), es una de las plantas medicinales más populares en Cuba habiendo sido empleada 
tradicionalmente en el tratamiento de la diabetes. es una de las plantas medicinales Cubanas más populares. Esta ha sido empleada 
tradicionalmente en el tratamiento de la diabetes. El objetivo de este estudio fue investigar el efecto del extracto acuoso de hojas de A 
cominia en un modelo de diabetes tipo 2 inducida por tratamiento con estreptozotocina en ratas neonatales. Se realizaron dos experimentos: 
a las 6 semanas de vida de las ratas, antes de comenzar la evaluación de la planta, y a las 11 semanas de vida de las ratas, después de la 
administración oral diaria de tres dosis de 0.25, 0.5 y 1.0 g/kg del extracto de A cominia durante 3 semanas y se evaluó la concentración de 
glucosa en sangre. A las 6 semanas de vida de las ratas, el grupo de animales diabéticos mostró un decrecimiento significativo en los valores 
de glucosa en sangre y el peso corporal comparado con el grupo control (p  0.05). A las 11 semanas de vida de las ratas, los grupos de 
animales diabéticos tratados con el extracto acuoso de A cominia decrecieron significativamente las concentraciones de glucosa en sangre 
comparado con el grupo diabético no tratado (p  0.05). Solamente los grupos tratados con 0.5 y 1.0 g/kg del extracto de A cominia 
mostraron una recuperación de los valores glicémicos normales. Por tanto, se puede concluir que el extracto acuoso de hojas de A cominia 
tiene propiedades antidiabéticas y puede ser eficaz en el tratamiento de la diabetes tipo 2.  
 
Palabras Clave: Allophylus cominia (L) Sw, propiedades antidiabéticas, actividad hipoglicémica, modelo de diabetes tipo 2 de ratas 
neonatales. 
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INTRODUCTION 
Diabetes mellitus is a metabolic disorder of multiple 
etiologies characterized by chronic hyperglycemia 
and altered metabolism of lipids, carbohydrates and 
proteins, due to defects in insulin secretion and /or 
insulin action. The two major forms of diabetes are: 
type 1 (insulin-dependent), characterized by 
destruction of the pancreatic beta cells, absolute 
deficiency insulin and requires insulin treatment to 
live and type 2 (non-insulin-dependent), 
characterized by insulin resistance in peripheral 
tissues and deficiency (not absolute) of insulin. Type 
2 diabetes is the most common form, which 
represents more than 90% of all cases (ADA, 2012).  
Conventional hypoglycemic agents cause 
inadequate efficacy and number of serious adverse 
effects. Thus, there are wide variety of new 
therapeutic agents, specially from plant extracts 
source, being examined for the treatment of type 2 
diabetes (Shubhapriya et al., 2008; Shen et al., 2008; 
Teng et al., 2011; Davis et al., 2012). 
Allophylus cominia (L) Sw (Sapindaceae), 
also known as Rhus cominia (L) or Schmidelia 
cominia Sw, which common name is palo de caja, 
caja or caja común, is one of the most well-known 
medicinal plant in Cuba. It was initially used as a 
remedy against gastrointestinal disorders, but was 
subsequently employed as a remedy for diabetes. It 
has also been reported in the use of tuberculosis and 
catarrhal diseases in general. In addition, medicinal 
properties against toothache and use as a blood 
purifier in venereal diseases have also been attributed 
to this plant (Roig, 1988).  
The phytochemical studies of the aqueous 
extract of leaves from A cominia revealed the 
presence of tannins, free amines, phenols, triterpenes 
and steroids. In addition, in this extract proteins, 
carbohydrates such as arabinose, xylose, galactose, 
glucose and fatty acids (lauric, miristic, palmitic, 
estearic and arachidonic ) were identified  (Véliz et 
al., 2004; Véliz et al., 2005).  
Several investigations have reported the 
hypoglycemic activity of A cominia aqueous extracts 
in normoglycemic rats (Melchor et al., 1999; Veliz et 
al., 2004) and type 1 diabetic animals models (Valls 
et al., 2000; Veliz, 2001; Safonts et al., 2007). 
However, there are no studies of this plant on animal 
models of type 2 diabetes.  
The aim of this study was to investigate the 
effect of A cominia leaves aqueous extract on type 2 
diabetes model induced by streptozotocin treatment in 
neonatal rats. 
 
MATERIALS AND METHODS 
Plant material 
Allophylus cominia (L) Sw (Sapindaceae) leaves were 
collected from forest of Cotilla (San José de Las 
Lajas, Mayabeque, Cuba) in the month of February 
(2008). Plants were taxonomically authenticated by 
Prof.  Fernando Franco Flores, in the Laboratory of  
Botany at the Agriculture University of Havana, 
Cuba and a voucher specimen of the plant is kept for 
reference (HFA-1769) in the Herbarium of this 
institution.  
 
Plant extract 
Fresh leaves of A. cominia were dried in a stove at 
37° C for 96 hours. The dry leaves were milled in 
fine particles of 5 mm. The plant extract was obtained 
from powder aqueous extraction at 95° C for 30 min, 
in a 10% (w/v) relation. The resulting extract was 
freeze dried. Dry extract was stored in plastic bottles 
in a desiccator for future experiments. 
 
Animals 
Pregnant Sprague-Dawley rats were purchased from 
stock at CENPALAB (Havana, Cuba). Animals were 
housed individually and maintained at 21 ± 2 C with 
a 12 h light/12 h dark cycle. Animals were allowed 
continuous access to water and fed ad libitum on 
standard pellet diet. All animals studies were carried 
out in accordance with the International Committee 
for Animal Care and in accordance with National 
Regulations for Animal Experimentation (R 15: Care 
and management of laboratory animals. Ethical 
Principles).  
 
Experimental Procedure 
Non-insulin-dependent diabetic animals model were 
produced as previously described (Permutt et al., 
1984). 2-d-old Sprague-Dawley pups were injected 
intraperitoneally with streptozotocin (90 mg/kg in 0.1 
M citrate buffer, pH 4.5). Controls were injected with 
an equal volume of citrate buffer. Animals were 
weaned at 24 d. The diabetic animals at 8 weeks old 
were randomly divided into four groups, 10 rats each. 
Group A was given 2 ml distilled water, groups B, C 
and D received respectively 0.25, 0.5 and 1.0 g/kg of 
Allophylus cominia aqueous extract orally during 21 
days daily using gavage. At the end of the 
experiment, the blood was collected from the orbital 
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plexus by capillary tubes into test tubes containing 
EDTA (ethylenediaminetetraacetic acid) at the time 
of sacrifice for plasma glucose level, which was 
determined by a standard glucose oxidase method.  
 
Oral glucose tolerance test (OGTT) 
Two experiments were carried out, one with 6 weeks 
old rats before starting with the plant evaluation and 
the other at the end of the assay. In both cases, rats 
were fasted for 18 hours before the OGTT and an oral 
administration of glucose (2 g/kg) was performed. 
The glucose concentration was measured using a 
glucose oxidase method, in the first experiment, at 
30, 50, 90 and 120 min after glucose administration. 
In the second experiment, at 50 min after glucose 
administration, selected before as the optimal time for 
the measurements. 
  
Animals weight 
The body weight of the rats was measured at 6 weeks 
old before starting OGTT in order to assess the 
significant changes of this indicator between control 
and diabetic groups. 
 
Statistical analysis 
Data are expressed as the mean ± standard error of 
mean (SEM). Results were analyzed by a ANOVA F-
test and after a Duncan's multiple range test. 
Statistical significance was considered at p  0.05. 
 
RESULTS AND DISCUSSION 
Figure 1 shows the results of oral glucose tolerance 
test in the type 2 diabetic rat model, which were 
measured plasma glucose concentrations at 30, 50, 90 
and 120 min, after oral administration a high dose of 
glucose (2 g/kg) to 6 weeks old rats with 18 h of 
fasting. It is observed that glucose levels were 
significantly increased in the group of diabetic 
animals compared to control group at 30 and 50 min 
(p  0.05). At 50 min was reached the highest value 
of glucose concentration and it was selected as the 
optimal time for measurements during the evaluation 
of a product with potential antidiabetic effect. It is 
shown, from 50 min of oral glucose administration, 
started to decrease the glucose levels, obtaining no 
statistically different values between control and 
diabetic groups at 90 and 120 min (p  0.05).  
 
 
Figure 1 
Oral Glucose Tolerance Test in type 2 diabetes model induced by streptozotocin treatment in neonatal rats. 
Data are expressed as the mean  ESM of 7 animals per group. (*) and (**) represent significant differences 
between treatments (p  0.05) and (p  0.01) respectively. C: control group, STZ: diabetic group. 
      * 
   ** 
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Figure 2 
Effect of type 2 diabetes on body weight in rats of 6 weeks of age. Data are expressed as the mean  ESM of 
10 animals per group. Different letters represent significant differences between groups (p  0.05). C: control 
group, STZ: diabetic group. 
 
 
 
 
 
 The figure 2 shows the average weight of 
controls and diabetic animals groups at 6 weeks old 
rats. It is observed that the group of diabetic animals 
showed an average weight value increased 
significantly compared to the control group (p  
0.05). 
The figure 3 shows the effect of reiterated 
administration daily during 21 days of A cominia 
aqueous extract (0.25, 0.5 and 1.0 g/kg) on blood 
glucose concentration at 11 weeks old rats. It is 
appreciated a significant increase of glycemia values 
in the diabetic group compared with control group of 
normal animals. In the group of animals treated with 
the lower dose of extract (0.25 g/kg), decreased 
significantly blood glucose values with respect to the 
group of diabetic animals (p  0.05), but they were  
still significantly increased compared to control 
group. There is not significant differences in the 
glycemia values between groups treated with 0.5 g/kg 
and 1.0 g/kg of A cominia extract. In both groups, 
blood glucose values were decreased significantly 
compared with the group treated with 0.25 g/kg of 
extract and with group of diabetic animals, but were 
not statistically different of the control group (p  
0.05), indicating recovery of normal glycemic values. 
These results demonstrate the efficacy of the aqueous 
extract from A cominia as antidiabetic in an in vivo 
model of type 2 diabetes mellitus. 
 
 
 
 
 
 
 
 
  a  b 
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Figure 3 
Effect of reiterated administration of aqueous extract from A cominia leaves on blood glucose levels in a 
model of type 2 diabetic rats. Data are expressed as the mean  ESM of 7 animals per group. Different letters 
represent differences between groups (p  0.05). Control group: normal animals treated with citrate buffer; 
Diabetic control: type 2 diabetic animals treated with Streptozotocin at 2-days-old; Ac groups: type 2 
diabetic animals treated with different doses of A cominia extract (0.25, 0.5 and 1.0 g/kg). 
 
The observed antidiabetic effects with A cominia 
aqueous extract in the present work, correspond to 
those obtained with other plant extracts tested in 
diabetic animal models. Other authors has reported 
that a proteoglycan, named FYGL (Fudan–Yueyang–
G. lucidum), screened from the fruiting bodies of 
Ganoderma lucidum, administered orally to type 2 
diabetic mice showed a decrease in plasma glucose 
level compared with the diabetic controls without 
drug treatment, comparable with diabetic mice 
treated with metformin, a clinical drug (Teng et al., 
2011). Other reports have informed that long-term 
feeding of the aqueous extract from guava leaves on 
type 2 diabetic rats significantly reduced blood 
glucose level, increased plasma insulin level in an 
oral glucose tolerance test, and stimulated activities 
of some glucose metabolic enzymes, however, the 
underlying mechanisms have not yet been clearly 
elucidated (Shen et al., 2008). Recently, studies with 
this extract revealed that the improvement of 
hyperglycemia is considered to be associated with the 
suppression of postprandial blood glucose elevation 
by alpha-glucosidase inhibition, although the exact 
mechanism remains uncertain (Deguchi and 
Miyazaki, 2010). Moreover, the oral administration 
of Annona squamosa hexane extract in ob/ob mice 
for 21 days caused significant reduction in glucose 
(27.7%; P < 0.01 vs. control) comparable to 
Rosiglitazone treatment (32.3%; P < 0.01 vs. control) 
and it also showed a significant reduction in plasma 
triglyceride comparable to Rosiglitazone (Davis et 
al., 2012). 
Several studies have demonstrated 
hypoglycemic activity of some phytochemical 
constituents present in the plant extracts. Thus, 
saponins obtained from a methanolic extract of 
Momordica cimbalaria, administered in a dose of 
175mg/kg for 30 days, to diabetic mice non-insulin 
dependent, decreased blood glucose and the proposed 
mechanism is to increase insulin secretion probably 
by regeneration of pancreatic β cells (Shubhapriya et 
al., 2008). Furthermore, Resveratrol, a red wine 
polyphenol antioxidant, administered to diabetic rats 
for 14 days decreased the plasma glucose 
concentration after 14 days at 25.3 ± 4.2% (Su et al., 
2006). It was also reported that Piceatannol, a 
  b 
  c    a 
  b   c 
  a 
a 
b 
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Resveratrol derivative, decreased hyperglycemia and 
impaired glucose tolerance in db/db mice, suggesting 
that this compound has antidiabetic properties so it 
can be used for the treatment of this disease 
(Minakawa et al., 2012). In other study it was found 
that genistein, an isoflavone, decreased levels of 
fasting glucose, in KK-Ay/Ta Jcl mice, an animal 
model of type 2 diabetes (Ha et al., 2012). 
Preliminary phytochemical studies of A cominia 
aqueous extract have detected the presence of 
polyphenolic compounds (Véliz et al., 2005), which 
could be involved in the hypoglycaemic effect. 
CONCLUSION 
In our study, the aqueous extract obtained from 
Allophylus cominia showed antidiabetic properties in 
a rat model of type 2 diabetes. Due to reducing 
glucose levels this plant might be used as a traditional 
herbal remedy for the treatment or prevention of 
certain metabolic diseases. 
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